Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: The role of prophylactic concomitant left atrial appendage closure during mitral repair in patients without atrial fibrillation (AF) is not defined.

Objectives: The objective was to compare long-term outcomes of patients who had left atrial appendage closure during mitral repair with those who did not in patients without AF.

Methods: A large national registry was used to identify 38,597 patients undergoing isolated mitral repair from 2010 to 2019. After excluding prior cardiac surgery, endocarditis, emergencies, and AF history, we identified 10,810 isolated mitral repairs. Of these, 1,875(17%) received closure and 8,935(83%) did not. Propensity score matching was performed on 27 baseline characteristics. The primary outcome of any stroke or thromboembolism was compared between matched groups using the cumulative incidence function in a Fine-Gray model with death as a competing risk. All-cause mortality was compared in a Cox-proportional hazard model.

Results: Propensity matching yielded 1,875 well-matched patient pairs (mean age:71 years, 45%female, median CHA2DS2-Vasc score 3.0). New post-operative AF was more common in the closure group (45%vs38.4%, p<0.01). There was no difference in 30-day mortality (1.2%vs1.1%, p=0.88). There was a reduction in stroke and thromboembolism over 5 years (6.4% vs 8.3%, HR: 0.74, 95%CI:0.57-0.96, p=0.023). There was no difference in 5-year survival (91% vs 91%, HR: 0.99, 95%CI:0.80-1.23, p=0.95).

Conclusions: Left atrial appendage closure at the time of isolated mitral repair in patients without AF may be associated with increased incidence of post-operative AF, but reduced late stroke and thromboembolism compared to mitral repair alone.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtcvs.2025.03.006DOI Listing

Publication Analysis

Top Keywords

mitral repair
16
left atrial
12
atrial appendage
12
isolated mitral
12
patients undergoing
8
undergoing isolated
8
atrial fibrillation
8
appendage closure
8
closure mitral
8
repair patients
8

Similar Publications

TMVR for the Treatment of Mitral Regurgitation: A State-of-the-Art Review.

Circ Cardiovasc Interv

September 2025

Department of Biomedical Sciences, Humanitas University, Pieve Emanuele-Milan, Italy (F.T., G.A., M.G., K.S., D.D., G.S., M.C.).

Mitral regurgitation is the most common valve disease worldwide. Despite its wide success in inoperable or high-risk surgical patients, transcatheter edge-to-edge repair remains limited by some anatomic features and the not negligible rate of significant residual regurgitation. Transcatheter mitral valve replacement has emerged as a viable alternative that promises to overcome these issues, but its development has been progressing slowly.

View Article and Find Full Text PDF

Background: Postoperative atrial fibrillation (POAF) commonly occurs following surgical repair of degenerative mitral regurgitation (DMR) and is associated with unfavorable outcomes. This study aimed to identify preoperative risk factors for acute POAF in patients undergoing mitral valve repair for DMR, with a specific focus on the role of preoperative echocardiography.

Methods: A retrospective study was conducted involving 1127 DMR patients who underwent mitral valve repair between 2017 and 2022.

View Article and Find Full Text PDF

Background: Long-term outcomes of transcatheter mitral valve edge-to-edge repair (TEER) are compared with medical therapy remain under investigation. This study evaluated the 3-year effects of MitraClip on mitral regurgitation (MR) severity, ventricular remodeling, and clinical outcomes in high surgical-risk patients.

Methods: A single-center retrospective cohort included 31 MitraClip patients (2016-2023) and 30 contemporaneous controls on maximally tolerated guideline-directed medical therapy.

View Article and Find Full Text PDF

Background: Pulmonary hypertension (PH) often coexists in patients undergoing transcatheter edge-to-edge mitral valve repair procedure (M-TEER). Its pre-procedural severity is considered a negative prognostic marker. Whether the post-procedural PH resulting from M-TEER can also serve as a long-term prognostic marker is unknown.

View Article and Find Full Text PDF

Objectives: Left ventricular vortex dynamics play a crucial role in cardiac function but are significantly altered by mitral valve diseases or surgical interventions. Such hemodynamic changes may lead to maladaptive intracardiac vortices, potentially triggering pathways associated with progressive left ventricular remodeling and thrombosis. This study assessed left ventricular hemodynamics under both physiological and pathological conditions using a biohybrid in vitro platform, aiming to analyze the impact of these conditions on cardiac function.

View Article and Find Full Text PDF